Latest News

No benefit found from oxytocin treatment for autism

The so-called trust hormone, oxytocin, may not improve the symptoms of children with autism, a new study has found. In a randomized controlled clinical trial of 38 boys with autism, half were given a nasal spray of oxytocin on four consecutive days. Compared to a placebo, oxytocin did not significantly improve emotion recognition, social interaction skills, repetitive behaviors, or general behavioral adjustment.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • A strong welfare state mitigates the impact of the Great Recession

  • Costs to treat bleeding strokes increases 10 years later

  • For brain hemorrhage, risk of death lower at high-volume hospitals

  • Nursery places for three-year-olds: introduction of free entitlement did not deliver long-term benefits for children?s development, new research finds

  • Boosting use of multi-sensory environments in dementia care

  • Clot dissolver tpa's tardy twin could aid in stroke recovery

  • Exposure therapy appears helpful in treating patients with prolonged grief

  • Omega 3 can help children with ADD, experts say

  • Music therapy reduces depression in children, adolescents

  • Teens whose parents exert more psychological control have trouble with closeness, independence

  •